AH Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIOA
BioAge Labs
BIOA
|
+$60.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maplebear
CART
|
+$98.4M |
| 2 |
SHPW
Shapeways Holdings, Inc. Common Stock
SHPW
|
+$423K |
| 3 |
Ginkgo Bioworks
DNA
|
+$10 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 39.02% |
| 2 | Technology | 22.92% |
| 3 | Healthcare | 21.65% |
| 4 | Consumer Discretionary | 13.5% |
| 5 | Industrials | 1.83% |
Similar funds
AH Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, AH Capital Management held 14 positions worth $1.14B, down 2.9% from $1.17B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
AH Capital Management withdrew a net $38.4M in Q3 2024, closing 1 position and reducing 2 holdings. Its most notable exit was Shapeways Holdings, Inc. Common Stock, an estimated $423K position sold in full.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.
Against the trend, AH Capital Management opened a new position in BioAge Labs worth $62.7M.
- AH Capital Management's largest Q3 2024 buy was BioAge Labs: 3,013,975 shares worth $62.7M.
- AH Capital Management's biggest Q3 2024 reduction was Maplebear, cutting an estimated $98.4M.
- AH Capital Management fully exited Shapeways Holdings, Inc. Common Stock in Q3 2024, selling an estimated $423K.
- AH Capital Management's ten largest holdings make up 99% of its $1.14B portfolio in Q3 2024.
- AH Capital Management opened 1 new position and closed 1 in Q3 2024.
- AH Capital Management's portfolio value fell 2.9% quarter-over-quarter to $1.14B.
Based on AH Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.